Analysis of LMP specific T cell immune response and clinical factors in stage III-IVa nasopharyngeal carcinoma
10.3760/cma.j.cn113030-20220228-00079
- VernacularTitle:Ⅲ-Ⅳa期鼻咽癌LMP特异性T细胞免疫反应与临床分析
- Author:
Haobo CUI
1
;
Ting CHEN
;
Peiwen FAN
;
Ruozheng WANG
Author Information
1. 中国医学科学院肿瘤免疫与放疗研究重点实验室/新疆肿瘤学重点实验室，乌鲁木齐 830011
- Keywords:
Nasopharyngeal carcinoma;
Epstein-Barr virus;
Latent membrane protein;
Specific T cell immune response;
Cultured intracellular cytokine staining
- From:
Chinese Journal of Radiation Oncology
2023;32(2):99-105
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the Epstein-Barr virus (EBV) latent infection membrane protein (LMP) 1 or LMP2 specific T cell immune response and clinical significance in stage III-IVa nasopharyngeal carcinoma (NPC), aiming to provide ideas and evidence for immunotherapy in NPC.Methods:Fifty-nine NPC patients admitted to the Affiliated Tumor Hospital of Xinjiang Medical University from February 2018 to October 2020 for primary treatment were collected. Peripheral blood monocytes (PBMCs) were stimulated by LMP antigen. Intracellular cytokine staining and flow cytometry were applied to study the expression levels of IL-2, IL-13, interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) from CD4 + T and CD8 + T cells, and then analyzed in conjunction with clinical factors. Results:The positive rates of total PBMCs to LMP1 and LMP2 in NPC patients were different. The positive rate of LMP1 specific CD4 + T cells was statistically higher in stage T 3-T 4 NPC than that in stage T 1-T 2 (51.0% vs. 10.0%, P=0.042). There were also differences in the expression of cytokines between LMP1 and LMP2, CD4 +T cells and CD8 +T cells. Survival analysis showed the 2-year and 3-year overall survival (OS) rates were 91.5% and 88.2%, and the 2-year and 3-year progression-free survival (PFS) rates were 83.3% and 75.3%. Univariate analysis suggested that smoking history, male and LMP1 stimulated IL-13 positive expression in CD4 + T cells affected the disease progression ( P=0.026, 0.045 and 0.006); multivariate analysis showed LMP1 stimulated IL-13 positive expression in CD4 + T cells and smoking history were the independent prognostic factors affecting PFS ( P=0.017, 0.019). Conclusions:LMP1 and LMP2 generate specific T-cell immune response in PBMCs of NPC patients, with differential expression in two T-cell subsets. LMP1 and LMP2 specific T cell immune response is associated with primary tumor size and metastatic lymph node volume. LMP1 stimulated IL-13 positive expression in CD4 + T cells and smoking history affects the disease progression.
